Your browser doesn't support javascript.
loading
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions.
Eastham, James A; Auffenberg, Gregory B; Barocas, Daniel A; Chou, Roger; Crispino, Tony; Davis, John W; Eggener, Scott; Horwitz, Eric M; Kane, Christopher J; Kirkby, Erin; Lin, Daniel W; McBride, Sean M; Morgans, Alicia K; Pierorazio, Phillip M; Rodrigues, George; Wong, William W; Boorjian, Stephen A.
Afiliación
  • Eastham JA; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Auffenberg GB; Urology of St. Louis, St. Louis, Missouri.
  • Barocas DA; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Chou R; Oregon Health & Science University, Portland, Oregon.
  • Crispino T; UsTOO, Las Vegas, Nevada.
  • Davis JW; MD Anderson Cancer Center, Houston, Texas.
  • Eggener S; The University of Chicago Medicine, Chicago, Illinois.
  • Horwitz EM; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Kane CJ; UC San Diego Health Physician Group, San Diego, California.
  • Kirkby E; American Urological Association, Linthicum, Maryland.
  • Lin DW; University of Washington Medical Center, Seattle, Washington.
  • McBride SM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Morgans AK; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Pierorazio PM; Penn Medicine, Philadelphia, Pennsylvania.
  • Rodrigues G; London Health Sciences Centre, London, Ontario, Canada.
  • Wong WW; Mayo Clinic, Phoenix, Arizona.
  • Boorjian SA; Mayo Clinic, Rochester, Minnesota.
J Urol ; 208(1): 26-33, 2022 07.
Article en En | MEDLINE | ID: mdl-35536141
PURPOSE: The summary presented herein represents Part III of the three-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of radiation and offering several future directions of further relevant study in patients diagnosed with clinically localized prostate cancer. Please refer to Parts I and II for discussion of risk assessment, staging, and risk-based management (Part I), and principles of active surveillance and surgery and follow-up (Part II). MATERIALS AND METHODS: The systematic review utilized to inform this guideline was conducted by an independent methodological consultant. A research librarian conducted searches in Ovid MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews. The methodology team supplemented searches of electronic databases with the studies included in the prior AUA review and by reviewing reference lists of relevant articles. RESULTS: The Clinically Localized Prostate Cancer Panel created evidence- and consensus-based guideline statements to aid clinicians in the management of patients with clinically localized prostate cancer. Statements regarding management of patients using radiation therapy as well as important future directions of research are detailed herein. CONCLUSIONS: This guideline aims to inform clinicians treating patients with clinically localized prostate cancer. Continued research and publication of high-quality evidence from future trials will be essential to further improve care for these men.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Idioma: En Revista: J Urol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Idioma: En Revista: J Urol Año: 2022 Tipo del documento: Article